Science Explorer Back to mapMap
Discussion
Researcher · Millennium Institute on Immunology and Immunotherapy · Chile

Felipe Melo-González

Felipe Melo-González publishes mostly in Immunology, Infectious Diseases and Molecular Biology, on topics such as SARS-CoV-2 and COVID-19 Research, Immune Cell Function and Interaction and COVID-19 Clinical Research Studies.

ORCID 0000-0002-3711-2407 OpenAlex
World rank
#501,303
of 7,710,434 ranked researchers
Rank in Chile
#695
of 20,642
Works
44
Citations
1.6k
Citations per work
37.2
h-index
19
i10-index 28Top 34% in Immunology
Felipe Melo-González

What does Felipe Melo-González research?

Felipe Melo-González's work is mostly in Medicine (37%), Immunology and Microbiology (24%), Biochemistry, Genetics and Molecular Biology (11%).

Health Sciences: 16 works · 37.1% of their workMedicine: 16 works · 37.1% of their workInfectious Diseases: 11 works · 24.2% of their workSurgery: 3 works · 6.1% of their workEpidemiology: 2 works · 3.8% of their workPhysiology: 1 works · 3.0% of their workLife Sciences: 16 works · 35.6% of their workImmunology and Microbiology: 11 works · 24.2% of their workImmunology: 11 works · 24.2% of their workBiochemistry, Genetics and Molecular Biology: 5 works · 11.4% of their workMolecular Biology: 5 works · 11.4% of their workEverything else: 12 works · 27.3% of their workTHEIR WORKFelipeMelo-González44works
Life Sciences36%Health Sciences37%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1637.1%
    1. Immunology and Microbiology1124.2%
    2. Biochemistry, Genetics and Molecular Biology511.4%
  3. Everything else1227.3%
  1. 1Immunology24% of their works
  2. 2Infectious Diseases24% of their works
  3. 3Molecular Biology11% of their works
  4. 4Surgery6% of their works
  5. 5Epidemiology4% of their works
  6. 6Physiology3% of their works

Research topics

Which keywords describe Felipe Melo-González's research?

The keywords of their largest research topics: ACE2 Receptor, SARS-CoV-2, Epidemiology, Coronavirus, Vaccine, Inflammatory Diseases, Natural Killer Cells and NK Cell Recognition.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. ACE2 Receptor252 topics
  2. SARS-CoV-2252 topics
  3. Epidemiology172 topics
  4. Coronavirus151 topic
  5. Vaccine151 topic
  6. Inflammatory Diseases112 topics
  7. NK Cell Recognition111 topic
  8. Natural Killer Cells111 topic
  9. Clinical Characteristics101 topic
  10. Thrombosis101 topic
  11. IL-3381 topic
  12. Innate Lymphoid Cells81 topic
  13. Diagnosis71 topic
  14. Eosinophilic Esophagitis71 topic
  15. Epitope Prediction71 topic
  16. Peptide-MHC Binding71 topic
  17. COVID-19 Vaccine41 topic
  18. Vaccine Hesitancy41 topic
  19. Gut Microbiota31 topic
  20. Microbial Communities31 topic

Where does Felipe Melo-González work?

Felipe Melo-González's main affiliation in the publication record is Millennium Institute on Immunology and Immunotherapy, Chile.

How many publications and citations does Felipe Melo-González have?

OpenAlex counts 44 works and 1,635 citations for Felipe Melo-González, an h-index of 19, ranking #501,303 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Felipe Melo-González. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.